Nanofiber-based delivery of therapeutic peptides to the brain
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
Nanofiber-based delivery of therapeutic peptides to the brain
M Mazza, R Notman, J Anwar, A Rodger, M Hicks… - ACS …, 2013 - research.monash.edu
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
[PDF][PDF] Nanofiber-Based Delivery of Therapeutic Peptides to the Brain
M Mazza, R Notman, J Anwar, A Rodger, M Hicks… - 2013 - academia.edu
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
Nanofiber-based delivery of therapeutic peptides to the brain
M Mazza, R Notman, J Anwar, A Rodger… - ACS …, 2013 - researchers.mq.edu.au
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
Nanofiber-based delivery of therapeutic peptides to the brain
M Mazza, R Notman, J Anwar, A Rodger… - ACS …, 2013 - research.manchester.ac.uk
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
Nanofiber-based delivery of therapeutic peptides to the brain
M Mazza, R Notman, J Anwar, A Rodger, MR Hicks… - ACS …, 2013 - wrap.warwick.ac.uk
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
[PDF][PDF] Nanofibre-Based Delivery of Therapeutic Peptides to the Brain
M Mazza, R Notman, J Anwar, A Rodger, M Hicks… - researchgate.net
We carried out a 40 ns simulation of a single pDal molecule in a cubic box of 11478 TIP3P 1
water molecules. The pDal molecule was modelled using the CHARMM all atom forcefield 2 …
water molecules. The pDal molecule was modelled using the CHARMM all atom forcefield 2 …
[引用][C] Nanofiber-Based Delivery of Therapeutic Peptides to the Brain
M Mazza, R Notman, J Anwar, A Rodger, M Hicks… - ACS Nano, 2013 - cir.nii.ac.jp
Nanofiber-Based Delivery of Therapeutic Peptides to the Brain | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Nanofiber-based delivery of therapeutic peptides to the brain.
M Mazza, R Notman, J Anwar, A Rodger, M Hicks… - ACS Nano, 2013 - europepmc.org
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
Nanofiber-based delivery of therapeutic peptides to the brain.
M Mazza, R Notman, J Anwar, A Rodger… - 1936 …, 2013 - escholar.manchester.ac.uk
The delivery of therapeutic peptides and proteins to the central nervous system is the
biggest challenge when developing effective neuropharmaceuticals. The central issue is …
biggest challenge when developing effective neuropharmaceuticals. The central issue is …